home / stock / ocul / ocul articles

OCUL Articles, Ocular Therapeutix Inc. - From 05/07/24

Stock Information
Company Name: Ocular Therapeutix Inc.
Stock Symbol: OCUL
Market: NASDAQ
Website: ocutx.com
Menu
OCUL OCUL Quote OCUL Short OCUL News OCUL Articles OCUL Message Board
Get OCUL Alerts

News, Short Squeeze, Breakout and More Instantly...
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Benzinga

BEDFORD, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) ("Ocular"), a biopharmaceutical company committed to enh...
BioNTech Reports Downbeat Earnings, Joins Medical Properties Trust And Other Big Stocks Moving Lower In Monday's Pre-Market Session | Benzinga

U.S. stock futures were higher this morning, with the Dow futures gaining over 100 points on Monday. Shares of BioNTech SE (NASDAQ:BNTX) fell sharp...

Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences | Benzinga

BEDFORD, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular", the "Company")), a biopharmaceutical company c...

Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024 | Benzinga

BEDFORD, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular", the "Company")), a biopharmaceutical company ...
Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024 | Benzinga

First quarter 2024 financial results to be reported on Tuesday, May 7, 2024 Investor Day to replace first quarter 2024 earnings conference call; q...

Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Shares of Super Micro Computer, Inc. (NASDAQ:SMCI) fell sharply during Friday's session. The company announced its third-quarter earnings date...

Ocular Therapeutix Highlights Early Data From Diabetes-Related Eye Disorder | Benzinga

On Thursday, Ocular Therapeutix Inc (NASDAQ:OCUL) announced topline results from the Phase 1 HELIOS study evaluating Axpaxli versus sham ...
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of Las Vegas Sands Corp. (NYSE:LVS) fell sharply during Thursday's session despite better-than-expected first-quarter results. The comp...

Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders | Benzinga

Nadia K. Waheed, MD, MPH, Appointed Chief Medical Officer; Peter K. Kaiser, MD, to Become Chief Development Officer; Andrea Gibson, PhD, Named Vi...

Ocular Therapeutix™ Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessich is Stepping Down as President and CEO | Benzinga

BEDFORD, Mass., April 15, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) ("Ocular"), a biopharmaceutical company committed to e...
Previous 10 Next 10